LAUSR

Key Points Question Can daily patient-reported outcome measurements (PROMs) be integrated into routine and supportive care for children with cancer? Findings This cohort study included 40 pediatric patients with cancer with 7082 therapy days who completed 4410 daily PROMs during a median follow-up of 145.5 days, yielding a completion rate of 60.1%. The most common moderate or severe symptom reported was physical functioning, followed by pain, sleep disturbance, and nausea and appetite loss. Meaning The findings of this cohort study suggest that completion of daily PROMs by pediatric patients with cancer can assist in their clinical management, identify adverse events, and help determine requisite medical interventions.